Search details
1.
Panitumumab plus trifluridine/tipiracil as anti-EGFR rechallenge therapy in patients with refractory RAS wild-type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial.
Int J Cancer
; 153(8): 1520-1528, 2023 10 15.
Article
in English
| MEDLINE | ID: mdl-37391938
2.
Targeting the EGFR signalling pathway in metastatic colorectal cancer.
Lancet Gastroenterol Hepatol
; 2024 Apr 29.
Article
in English
| MEDLINE | ID: mdl-38697174
3.
Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer: A Nonrandomized Controlled Trial.
JAMA Netw Open
; 7(4): e245635, 2024 Apr 01.
Article
in English
| MEDLINE | ID: mdl-38592721
4.
Case report of unusual synchronous anal and rectal squamous cell carcinoma: clinical and therapeutic lesson.
Front Oncol
; 13: 1187623, 2023.
Article
in English
| MEDLINE | ID: mdl-37361596
Results
1 -
4
de 4
1
Next >
>>